Biomaterials & Biotechnology
Building biomaterials, running extraction, or developing a biorefinery?
This pathway covers the upstream and material-science end of the seaweed sector: extraction operations, biorefinery development, bioplastics, packaging, and any business where seaweed is the raw feedstock for a technical material output. The tools here focus on facility economics, capital planning, compound yields, and compliance.
Product categories covered — hover for a definition
Bioplastics
Materials made fully or partly from biological feedstocks (like alginate) that can replace conventional petroleum-based plastics, often with improved biodegradability. Seaweed-derived bioplastics are still largely at the research and pilot stage but are a high-growth area globally.
Biorefinery
An integrated facility that processes seaweed biomass into multiple co-products including compounds, energy, and materials to maximise value from each batch of raw material. Analogous to a petroleum refinery but built around biological feedstocks.
Extraction
The physical or chemical process of isolating specific compounds (alginate, fucoidan, carrageenan) from seaweed biomass for use in downstream products. Extraction method significantly affects compound quality, yield, and environmental footprint.
Packaging
Seaweed-derived materials used as sustainable alternatives to plastic packaging including films, wraps, coatings, and formed containers derived from alginate or agar. A growing commercial category driven by single-use plastic regulation.
Technical Materials
Engineered materials derived from seaweed polysaccharides with defined physical properties. Used in wound care, 3D bioprinting scaffolds, and specialty industrial applications where precise material behaviour is required.
Wound Care
Medical-grade alginate dressings and gels used in clinical wound management. Alginate fibres form a gel on contact with wound exudate, maintaining a moist healing environment. An established commercial category with strong clinical evidence.
3D Bioprinting
Alginate-based bioinks that allow living cells to be printed into three-dimensional tissue structures for regenerative medicine, drug testing, and research applications. Alginate is valued for its biocompatibility and gentle crosslinking chemistry.
Cleantech
Technologies derived from or processing seaweed that reduce environmental impact, including carbon capture cultivation, bioenergy production, bioplastic substitution, and nutrient cycling systems. Increasingly supported by cleantech and climate funds.
Mobile: definitions appear in the compounds section below.
Key compounds & feedstocks
Primary compounds and extraction outputs relevant to biomaterial and biotech applications. Choosing the right compound determines your extraction process, your facility specifications, and which industrial or medical markets your product can enter.
Tools for this pathway
Tools relevant to biomaterial development, biorefinery operations, and extraction businesses.
Economics Lab: Extraction Calculator
EconomicsModel the yield, cost, and economics of seaweed extraction. Calculate solvent ratios, energy inputs, and compound yields for alginate, fucoidan, and carrageenan extraction processes.
Open →Facility Cost Explorer
Capital AccessSee what processing facilities involve, from container drying units to full biorefineries, what belongs in a budget, and how they get financed. Specific cost figures are under review.
Open →Product Specifications Library
SpecificationsIndustrial-grade specifications for alginate, agar, and carrageenan, including viscosity grades, gel strengths, moisture limits, and industrial application references.
Open →Facility Compliance Guide
Market ReadinessUnderstand the compliance requirements for operating a seaweed processing facility in BC, including environmental, food safety, and occupational health obligations by facility type.
Open →Grant & Incentive Navigator
Capital AccessFind cleantech, bioeconomy, and industrial innovation grants relevant to biorefinery and biomaterial development, including NRC IRAP, SDTC, and provincial programs.
Open →Investor Readiness Scorecard
Capital AccessAssess your biotech or biomaterials venture across twelve investor dimensions before approaching cleantech funds or impact investors.
Open →Builders in this space
See who is running extraction operations, developing biomaterials, and building biorefinery infrastructure in Canada.
Explore Builders →Planning a facility or extraction operation?
Biorefinery development involves complex capital planning, permitting, and process design decisions. Our advisors can help you scope your facility, build your business case, and identify the right funding programs.
Talk to an advisor